Insiders · Profile

Dalton Barbara

Director at Enliven Therapeutics. Filing since 16 Mar 2020. CIK 0001591318

Company

Date

Role

Action

Shares

Amount

Of holding

ELVN Enliven Therapeutics, Inc.

16 Mar 2020

Director

Bought

312,500

$5.00M

25.1%

1 decision on file.